POSC
Price
$1.09
Change
+$0.04 (+3.81%)
Updated
Dec 20 closing price
QLIS
Price
$0.27
Change
-$0.01 (-3.57%)
Updated
Dec 19 closing price
Ad is loading...

POSC vs QLIS

Header iconPOSC vs QLIS Comparison
Open Charts POSC vs QLISBanner chart's image
Positron
Price$1.09
Change+$0.04 (+3.81%)
Volume$11.3K
CapitalizationN/A
Qualis Innovations
Price$0.27
Change-$0.01 (-3.57%)
Volume$100
CapitalizationN/A
POSC vs QLIS Comparison Chart
Loading...
POSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QLIS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
POSC vs. QLIS commentary
Dec 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is POSC is a StrongBuy and QLIS is a Hold.

COMPARISON
Comparison
Dec 22, 2024
Stock price -- (POSC: $1.09 vs. QLIS: $0.27)
Brand notoriety: POSC and QLIS are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: POSC: 108% vs. QLIS: 72%
Market capitalization -- POSC: $442.55K vs. QLIS: $2.2M
POSC [@Medical Specialties] is valued at $442.55K. QLIS’s [@Medical Specialties] market capitalization is $2.2M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

POSC’s FA Score shows that 1 FA rating(s) are green whileQLIS’s FA Score has 1 green FA rating(s).

  • POSC’s FA Score: 1 green, 4 red.
  • QLIS’s FA Score: 1 green, 4 red.
According to our system of comparison, POSC is a better buy in the long-term than QLIS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

POSC’s TA Score shows that 6 TA indicator(s) are bullish while QLIS’s TA Score has 3 bullish TA indicator(s).

  • POSC’s TA Score: 6 bullish, 3 bearish.
  • QLIS’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, POSC is a better buy in the short-term than QLIS.

Price Growth

POSC (@Medical Specialties) experienced а +3.57% price change this week, while QLIS (@Medical Specialties) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.51%. For the same industry, the average monthly price growth was +1.92%, and the average quarterly price growth was +0.64%.

Industries' Descriptions

@Medical Specialties (-1.51% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
QLIS($2.2M) has a higher market cap than POSC($443K). QLIS YTD gains are higher at: -11.130 vs. POSC (-30.732). QLIS has higher annual earnings (EBITDA): -546.13K vs. POSC (-699K). POSC has more cash in the bank: 28K vs. QLIS (16.1K). QLIS has less debt than POSC: QLIS (62.4K) vs POSC (962K). POSC has higher revenues than QLIS: POSC (1.24M) vs QLIS (0).
POSCQLISPOSC / QLIS
Capitalization443K2.2M20%
EBITDA-699K-546.13K128%
Gain YTD-30.732-11.130276%
P/E Ratio0.09N/A-
Revenue1.24M0-
Total Cash28K16.1K174%
Total Debt962K62.4K1,542%
FUNDAMENTALS RATINGS
POSC vs QLIS: Fundamental Ratings
POSC
QLIS
OUTLOOK RATING
1..100
8793
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
93
Overvalued
PROFIT vs RISK RATING
1..100
38100
SMR RATING
1..100
1005
PRICE GROWTH RATING
1..100
5755
P/E GROWTH RATING
1..100
10063
SEASONALITY SCORE
1..100
95n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

POSC's Valuation (24) in the null industry is significantly better than the same rating for QLIS (93). This means that POSC’s stock grew significantly faster than QLIS’s over the last 12 months.

POSC's Profit vs Risk Rating (38) in the null industry is somewhat better than the same rating for QLIS (100). This means that POSC’s stock grew somewhat faster than QLIS’s over the last 12 months.

QLIS's SMR Rating (5) in the null industry is significantly better than the same rating for POSC (100). This means that QLIS’s stock grew significantly faster than POSC’s over the last 12 months.

QLIS's Price Growth Rating (55) in the null industry is in the same range as POSC (57). This means that QLIS’s stock grew similarly to POSC’s over the last 12 months.

QLIS's P/E Growth Rating (63) in the null industry is somewhat better than the same rating for POSC (100). This means that QLIS’s stock grew somewhat faster than POSC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
POSCQLIS
RSI
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 2 days ago
56%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
61%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
51%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
62%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
63%
Advances
ODDS (%)
Bullish Trend 2 days ago
67%
N/A
Declines
ODDS (%)
Bearish Trend 10 days ago
83%
Bearish Trend 3 days ago
63%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
48%
View a ticker or compare two or three
Ad is loading...
POSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QLIS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BCIFX227.713.60
+1.61%
Blue Chip Investor
DESUX22.990.29
+1.28%
DWS ESG Core Equity R6
EPSPX22.030.23
+1.06%
NYLI Epoch Global Equity Yield Class A
RRIGX16.790.06
+0.36%
T. Rowe Price International Value Eq R
FMPAX29.42-2.25
-7.11%
Fidelity Advisor Mid Cap Value A

POSC and

Correlation & Price change

A.I.dvisor tells us that POSC and SLDX have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that POSC and SLDX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To POSC
1D Price
Change %
POSC100%
+3.57%
SLDX - POSC
27%
Poorly correlated
N/A
GMED - POSC
20%
Poorly correlated
+0.84%
RSMDF - POSC
9%
Poorly correlated
-4.36%
RSCF - POSC
8%
Poorly correlated
-0.88%
PFGTF - POSC
7%
Poorly correlated
N/A
More

QLIS and

Correlation & Price change

A.I.dvisor tells us that QLIS and QDEL have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that QLIS and QDEL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QLIS
1D Price
Change %
QLIS100%
N/A
QDEL - QLIS
31%
Poorly correlated
+4.28%
POSC - QLIS
5%
Poorly correlated
+3.57%
RYLPF - QLIS
4%
Poorly correlated
N/A
RDGL - QLIS
3%
Poorly correlated
+10.00%
RSCF - QLIS
1%
Poorly correlated
-0.88%
More